Literature DB >> 17226071

Effect of different cyclooxygenase inhibitors on gastric adaptive cytoprotection induced by 20% ethanol.

Alessandra Gambero1, Marta Maróstica, Tagliane Liza Becker, José Pedrazzoli.   

Abstract

In this study, we evaluated the effect of two different dosages of therapeutically prescribed nonsteroidal anti-inflammatory drugs (NSAIDs), ibuprofen, diclofenac, nimesulide, meloxicam, and celecoxib (ED80 for COX-1 and COX-2) on normal gastric mucosa and mucosa, previously exposed to 20% ethanol. At COX-2-inhibiting dosages, the NSAIDs tested were nonulcerogenic, and the same response profile was observed in "adapted" stomachs. Interestingly, low doses of nimesulide and celecoxib increase the levels of Prostaglandin E(2) and COX-2, and protect against subsequent 100% ethanol exposition, suggesting that these drugs may act as "mild irritants" to gastric mucosa. The ulcerogenic response to NSAIDs was prevented by the previous 20% ethanol exposition, probably the result of nitric oxide synthesis, because PGE(2) levels in gastric mucosa were reduced by these agents and a concomitant nitric oxide blockade reversed this protection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17226071     DOI: 10.1007/s10620-006-9487-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  32 in total

1.  Meloxicam inhibits prostaglandin E(2) generation via cyclooxygenase 2 in the inflammatory site but not that via cyclooxygenase 1 in the stomach.

Authors:  K Ogino; K Hatanaka; M Kawamura; T Ohno; Y Harada
Journal:  Pharmacology       Date:  2000-11       Impact factor: 2.547

2.  Molecular mechanism of adaptive cytoprotection induced by ethanol in human gastric cells.

Authors:  Shinji Tsutsumi; Shinji Mima; Wataru Tomisato; Tatsuya Hoshino; Tomofusa Tsuchiya; Tohru Mizushima
Journal:  Exp Biol Med (Maywood)       Date:  2003-10

3.  Risk of serious upper gastrointestinal toxicity with over-the-counter nonaspirin nonsteroidal anti-inflammatory drugs.

Authors:  James D Lewis; Stephen E Kimmel; A Russell Localio; David C Metz; John T Farrar; Lisa Nessel; Colleen Brensinger; Karen McGibney; Brian L Strom
Journal:  Gastroenterology       Date:  2005-12       Impact factor: 22.682

4.  The effect of nimesulide on the indomethacin- and ethanol-induced gastric ulcer in rats.

Authors:  Halis Süleyman; Fatih Akçay; Konca Altinkaynak
Journal:  Pharmacol Res       Date:  2002-02       Impact factor: 7.658

5.  Expression of cyclooxygenase (COX)-1 and COX-2 in adaptive cytoprotection induced by mild stress.

Authors:  T Brzozowski; P C Konturek; S J Konturek; D Drozdowicz; R Pajdo; M Pawlik; I Brzozowska; E G Hahn
Journal:  J Physiol Paris       Date:  2000 Mar-Apr

Review 6.  Physiological, immunohistochemical and molecular aspects of gastric adaptation to stress, aspirin and to H. pylori-derived gastrotoxins.

Authors:  P C Konturek
Journal:  J Physiol Pharmacol       Date:  1997-03       Impact factor: 3.011

7.  Action of ethanol and some alcoholic beverages on gastric acid secretion and release of gastrin in humans.

Authors:  M V Singer; C Leffmann; V E Eysselein; H Calden; H Goebell
Journal:  Gastroenterology       Date:  1987-12       Impact factor: 22.682

8.  Vinegar is a dietary mild irritant to the rat gastric mucosa.

Authors:  Y Nobuhara; K Takeuchi; S Okabe
Journal:  Jpn J Pharmacol       Date:  1986-05

9.  Cholecystokinin secretagogue-induced gastroprotection: role of nitric oxide and blood flow.

Authors:  Sonlee D West; Kenneth S Helmer; Lily K Chang; Yan Cui; George H Greeley; David W Mercer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-11-20       Impact factor: 4.052

10.  Differing profiles of prostaglandin formation inhibition between selective prostaglandin H synthase-2 inhibitors and conventional NSAIDs in inflammatory and non-inflammatory sites of the rat.

Authors:  Y Harada; M Kawamura; K Hatanaka; M Saito; M Ogino; T Ohno; K Ogino; Q Yang
Journal:  Prostaglandins Other Lipid Mediat       Date:  1998-04       Impact factor: 3.072

View more
  6 in total

1.  Gastroprotective action of Cochinchina momordica seed extract is mediated by activation of CGRP and inhibition of cPLA(2)/5-LOX pathway.

Authors:  Jung Mook Kang; Nayoung Kim; Bongcheol Kim; Joo-Hyon Kim; Bong-Yong Lee; Ji Hyun Park; Mi Kyoung Lee; Hye Seung Lee; In-Jin Jang; Joo Sung Kim; Hyun Chae Jung; In Sung Song
Journal:  Dig Dis Sci       Date:  2009-12       Impact factor: 3.199

2.  Preventive Effect of Aspirin Eugenol Ester on Thrombosis in κ-Carrageenan-Induced Rat Tail Thrombosis Model.

Authors:  Ning Ma; Xi-Wang Liu; Ya-Jun Yang; Jian-Yong Li; Isam Mohamed; Guang-Rong Liu; Ji-Yu Zhang
Journal:  PLoS One       Date:  2015-07-20       Impact factor: 3.240

3.  Comparison of Indomethacin, Diclofenac and Aspirin-Induced Gastric Damage according to Age in Rats.

Authors:  Pyoung Ju Seo; Nayoung Kim; Joo-Hyon Kim; Byoung Hwan Lee; Ryoung Hee Nam; Hye Seung Lee; Ji Hyun Park; Mi Kyoung Lee; Hyun Chang; Hyun Chae Jung; In Sung Song
Journal:  Gut Liver       Date:  2012-04-17       Impact factor: 4.519

4.  Gastroprotective effect of Cochinchina momordica seed extract in nonsteroidal anti-inflammatory drug-induced acute gastric damage in a rat model.

Authors:  Ji Hwan Lim; Joo-Hyun Kim; Nayoung Kim; Byoung Hwan Lee; Pyoung Ju Seo; Jung Mook Kang; So Young Jo; Ji Hyun Park; Ryoung Hee Nam; Hyun Chang; Jin-Won Kwon; Dong Ho Lee
Journal:  Gut Liver       Date:  2013-11-05       Impact factor: 4.519

5.  Gastroprotective Effects of PMK-S005 against Ethanol-Induced Acute Gastric Damage in Rats.

Authors:  Yoon Jeong Choi; Nayoung Kim; Ju Yup Lee; Ryoung Hee Nam; Ji Hyung Seo; Seonmin Lee; Hee Jin Kim; Yoon Jin Choi; Hye Seung Lee; Dong Ho Lee
Journal:  Gut Liver       Date:  2016-05-23       Impact factor: 4.519

6.  Impact of Aspirin Eugenol Ester on Cyclooxygenase-1, Cyclooxygenase-2, C-Reactive Protein, Prothrombin and Arachidonate 5-Lipoxygenase in Healthy Rats.

Authors:  Ning Ma; Guan-Zhou Yang; Xi-Wang Liu; Ya-Jun Yang; Isam Mohamed; Guang-Rong Liu; Jian-Yong Li
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.